packageRoquinimex

roquinimex

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Roquinimex (Linomide) is an immunostimulant that was investigated as an immunologic adjuvant and angiogenesis inhibitor for immune-related conditions such as multiple sclerosis. It remains experimental and is not an approved medicine; trials were halted after serious cardiovascular side effects.

Summary written by glm-5.3-flash from Wikidata Q964482 and the WHO ATC classification; not checked by a person.

name:roquinimex
ATC codes:L03AX02
DrugBank:DB11366
PubChem CID:54676478
ChEBI:92056
Wikidata:Q964482
formula:C18H16N2O3
molar mass:308.337 g/mol (PubChem CID 54676478)
logP:2.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown